Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,572 | 107 | 82.6% |
| Consulting Fee | $750.00 | 2 | 17.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Beaver-Visitec International, Inc. | $750.00 | 2 | $0 (2023) |
| Allergan, Inc. | $504.60 | 7 | $0 (2022) |
| Alcon Laboratories Inc | $373.97 | 7 | $0 (2018) |
| Alcon Vision LLC | $363.40 | 11 | $0 (2024) |
| Oyster Point Pharma, Inc. | $362.88 | 11 | $0 (2024) |
| Aerie Pharmaceuticals, Inc. | $349.57 | 5 | $0 (2021) |
| ABBVIE INC. | $291.35 | 10 | $0 (2024) |
| Horizon Therapeutics plc | $230.67 | 11 | $0 (2023) |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $209.11 | 8 | $0 (2024) |
| Bausch & Lomb, a division of Bausch Health US, LLC | $200.12 | 6 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $675.73 | 26 | ABBVIE INC. ($291.35) |
| 2023 | $1,125 | 23 | Beaver-Visitec International, Inc. ($400.00) |
| 2022 | $694.55 | 14 | Beaver-Visitec International, Inc. ($350.00) |
| 2021 | $426.90 | 13 | Aerie Pharmaceuticals, Inc. ($224.22) |
| 2020 | $24.99 | 1 | Bausch & Lomb, a division of Bausch Health US, LLC ($24.99) |
| 2019 | $711.04 | 15 | Allergan Inc. ($361.28) |
| 2018 | $476.22 | 12 | Alcon Laboratories Inc ($224.83) |
| 2017 | $187.47 | 5 | Alcon Laboratories Inc ($149.14) |
All Payment Transactions
109 individual payment records from CMS Open Payments — Page 1 of 5
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/04/2024 | Alcon Vision LLC | HYDRUS Microstent (Device) | Food and Beverage | In-kind items and services | $22.48 | General |
| Category: Ophthalmology | ||||||
| 11/26/2024 | Bausch & Lomb Americas Inc. | VYZULTA (Drug), MIEBO | Food and Beverage | In-kind items and services | $15.19 | General |
| Category: Ophthalmology | ||||||
| 10/29/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | Cequa (Drug) | Food and Beverage | In-kind items and services | $34.32 | General |
| Category: Ophthalmology | ||||||
| 09/17/2024 | ABBVIE INC. | LUMIGAN (Drug) | Food and Beverage | In-kind items and services | $5.74 | General |
| Category: EYE CARE | ||||||
| 08/27/2024 | Bausch & Lomb Americas Inc. | VYZULTA (Drug), MIEBO | Food and Beverage | In-kind items and services | $16.37 | General |
| Category: Ophthalmology | ||||||
| 07/25/2024 | Alcon Vision LLC | HYDRUS Microstent (Device) | Food and Beverage | In-kind items and services | $20.50 | General |
| Category: Ophthalmology | ||||||
| 05/21/2024 | Oyster Point Pharma, Inc. | TYRVAYA (Drug) | Food and Beverage | In-kind items and services | $22.01 | General |
| Category: Dry eyes | ||||||
| 05/15/2024 | ABBVIE INC. | DURYSTA (Drug) | Food and Beverage | In-kind items and services | $6.11 | General |
| Category: EYE CARE | ||||||
| 05/08/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | Cequa (Drug) | Food and Beverage | In-kind items and services | $35.06 | General |
| Category: Ophthalmology | ||||||
| 05/06/2024 | ABBVIE INC. | DURYSTA (Drug) | Food and Beverage | In-kind items and services | $33.78 | General |
| Category: EYE CARE | ||||||
| 04/22/2024 | ABBVIE INC. | LUMIGAN (Drug) | Food and Beverage | In-kind items and services | $22.32 | General |
| Category: EYE CARE | ||||||
| 04/22/2024 | Tarsus Pharmaceuticals, Inc. | XDEMVY (Drug) | Food and Beverage | In-kind items and services | $18.63 | General |
| Category: DEMODEX BLEPHARITIS | ||||||
| 04/09/2024 | ABBVIE INC. | LUMIGAN (Drug) | Food and Beverage | In-kind items and services | $7.44 | General |
| Category: EYE CARE | ||||||
| 04/05/2024 | ABBVIE INC. | XEN GLAUCOMA TREATMENT SYSTEM (Device) | Food and Beverage | In-kind items and services | $121.82 | General |
| Category: EYE CARE | ||||||
| 03/29/2024 | ABBVIE INC. | DURYSTA (Drug) | Food and Beverage | In-kind items and services | $20.57 | General |
| Category: EYE CARE | ||||||
| 03/26/2024 | Alcon Vision LLC | HYDRUS Microstent (Device) | Food and Beverage | In-kind items and services | $23.38 | General |
| Category: Ophthalmology | ||||||
| 03/13/2024 | Tarsus Pharmaceuticals, Inc. | XDEMVY (Drug) | Food and Beverage | In-kind items and services | $24.14 | General |
| Category: DEMODEX BLEPHARITIS | ||||||
| 03/12/2024 | ABBVIE INC. | DURYSTA (Drug) | Food and Beverage | In-kind items and services | $18.55 | General |
| Category: EYE CARE | ||||||
| 03/06/2024 | Oyster Point Pharma, Inc. | TYRVAYA (Drug) | Food and Beverage | In-kind items and services | $17.27 | General |
| Category: Dry eyes | ||||||
| 03/04/2024 | Amgen Inc. | TEPEZZA (Biological) | Food and Beverage | In-kind items and services | $26.75 | General |
| Category: Inflammation/Rare Disease | ||||||
| 02/23/2024 | ABBVIE INC. | DURYSTA (Drug) | Food and Beverage | In-kind items and services | $23.85 | General |
| Category: EYE CARE | ||||||
| 02/22/2024 | Amgen Inc. | TEPEZZA (Biological) | Food and Beverage | In-kind items and services | $29.64 | General |
| Category: Inflammation/Rare Disease | ||||||
| 02/21/2024 | Ocular Therapeutix, Inc. | DEXTENZA (Drug) | Food and Beverage | In-kind items and services | $20.17 | General |
| Category: Corticosteroid intracanalicular insert | ||||||
| 02/07/2024 | ABBVIE INC. | DURYSTA (Drug) | Food and Beverage | In-kind items and services | $31.17 | General |
| Category: EYE CARE | ||||||
| 01/28/2024 | Amgen Inc. | TEPEZZA (Biological) | Food and Beverage | In-kind items and services | $25.90 | General |
| Category: Inflammation/Rare Disease | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 19 | 4,569 | 12,873 | $2.6M | $515,788 |
| 2022 | 17 | 4,168 | 12,585 | $2.5M | $480,775 |
| 2021 | 21 | 4,286 | 12,444 | $2.6M | $529,095 |
| 2020 | 20 | 3,803 | 9,052 | $2.2M | $439,775 |
All Medicare Procedures & Services
85 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 66984 | Removal of cataract with insertion of prosthetic lens | Facility | 2023 | 313 | 7,773 | $1.1M | $193,577 | 17.9% |
| 92014 | Established patient complete exam of visual system | Office | 2023 | 1,195 | 1,261 | $461,526 | $113,663 | 24.6% |
| 92012 | Established patient problem focused exam of visual system | Office | 2023 | 702 | 969 | $245,157 | $62,667 | 25.6% |
| 92004 | New patient complete exam of visual system | Office | 2023 | 245 | 245 | $107,310 | $26,104 | 24.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 180 | 180 | $84,960 | $20,080 | 23.6% |
| 92083 | Exam of visual field with extended testing | Office | 2023 | 297 | 300 | $88,579 | $12,600 | 14.2% |
| 92136 | Measurement of corneal curvature and depth of eye | Office | 2023 | 339 | 341 | $96,250 | $12,117 | 12.6% |
| 66821 | Removal of recurring cataract in lens capsule using a laser | Facility | 2023 | 37 | 38 | $44,685 | $10,515 | 23.5% |
| 66821 | Removal of recurring cataract in lens capsule using a laser | Office | 2023 | 35 | 37 | $41,706 | $10,154 | 24.3% |
| 92250 | Photography of the retina | Office | 2023 | 308 | 311 | $70,400 | $8,816 | 12.5% |
| 92133 | Imaging of optic nerve | Office | 2023 | 321 | 342 | $45,672 | $8,550 | 18.7% |
| 66982 | Complex removal of cataract with insertion of prosthetic lens | Facility | 2023 | 12 | 442 | $54,542 | $8,548 | 15.7% |
| 65855 | Laser repair to improve eye fluid flow | Facility | 2023 | 37 | 37 | $60,720 | $7,979 | 13.1% |
| 68761 | Closure of tear duct opening using plug | Office | 2023 | 21 | 62 | $27,776 | $5,486 | 19.8% |
| 92136 | Measurement of corneal curvature and depth of eye | Facility | 2023 | 213 | 213 | $58,575 | $5,284 | 9.0% |
| 92020 | Exam of the internal drainage system of eye | Office | 2023 | 190 | 190 | $15,200 | $3,615 | 23.8% |
| 92002 | New patient problem focused exam of visual system | Office | 2023 | 45 | 45 | $10,845 | $2,288 | 21.1% |
| 92134 | Imaging of retina | Office | 2023 | 43 | 49 | $6,860 | $1,521 | 22.2% |
| 67800 | Removal of chronic growth of eyelid | Office | 2023 | 12 | 13 | $4,979 | $1,126 | 22.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 11 | 11 | $3,421 | $907.15 | 26.5% |
| 67820 | Removal of eyelashes using forceps | Office | 2023 | 13 | 14 | $2,072 | $189.02 | 9.1% |
| 66984 | Removal of cataract with insertion of prosthetic lens | Facility | 2022 | 286 | 8,153 | $1.1M | $180,934 | 16.8% |
| 92014 | Established patient complete exam of visual system | Office | 2022 | 1,129 | 1,211 | $443,226 | $104,817 | 23.6% |
| 92012 | Established patient problem focused exam of visual system | Office | 2022 | 675 | 985 | $249,205 | $62,106 | 24.9% |
| 92004 | New patient complete exam of visual system | Office | 2022 | 242 | 242 | $105,996 | $23,365 | 22.0% |
About Dr. Samuel Allen, M.D
Dr. Samuel Allen, M.D is a Ophthalmology healthcare provider based in Lawrence, Massachusetts. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/25/2005. The National Provider Identifier (NPI) number assigned to this provider is 1649253444.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Samuel Allen, M.D has received a total of $4,322 in payments from pharmaceutical and medical device companies, with $675.73 received in 2024. These payments were reported across 109 transactions from 23 companies. The most common payment nature is "Food and Beverage" ($3,572).
As a Medicare-enrolled provider, Allen has provided services to 16,826 Medicare beneficiaries, totaling 46,954 services with total Medicare billing of $2.0M. Data is available for 4 years (2020–2023), covering 85 distinct procedure/service records.
Practice Information
- Specialty Ophthalmology
- Other Specialties Ophthalmology
- Location Lawrence, MA
- Active Since 11/25/2005
- Last Updated 11/25/2013
- Taxonomy Code 207W00000X
- Entity Type Individual
- NPI Number 1649253444
Products in Payments
- TYRVAYA (Drug) $362.88
- RESTASIS (Drug) $236.30
- TEPEZZA (Drug) $230.67
- VYZULTA (Drug) $227.08
- LUMIGAN (Drug) $173.23
- Cequa (Drug) $151.75
- DURYSTA (Drug) $134.03
- Rhopressa (Drug) $125.35
- rhopressa (Drug) $125.00
- rocklatan (Drug) $121.87
- XEN GLAUCOMA TREATMENT SYSTEM (Device) $121.82
- ACTIVEFOCUS (Device) $117.66
- TEPEZZA (Biological) $114.86
- VUITY (Drug) $107.91
- EYSUVIS (Drug) $104.77
- XIIDRA (Drug) $104.74
- ReSTOR (Device) $103.13
- ORA (Device) $89.28
- AcrySof (Device) $87.74
- Centurion (Device) $72.67
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Ophthalmology Doctors in Lawrence
Robert Kwon, M.d, M.D
Ophthalmology — Payments: $6,175
Dr. Rubin Brecher, Md, MD
Ophthalmology — Payments: $2,333
Thomas Pappavaselio, M.d, M.D
Ophthalmology — Payments: $1,704
Dr. Michael Mulhern, M.d., Ph.d, M.D., PH.D
Ophthalmology — Payments: $1,377
Mary Lange, M.d, M.D
Ophthalmology — Payments: $1,258
Dr. M Scott Hickman, M.d, M.D
Ophthalmology — Payments: $1,174